Integrated analysis identified MARK4 as a prognostic and immunomodulatory biomarker in oral squamous cell carcinoma
Xinyue Zhang, Xiaoxue Shen, Sujun Hu, Rui Yao · 2026
Read Integrated analysis identified MARK4 as a prognostic and immunomodulatory biomarker in oral squamous cell carcinoma by Xinyue Zhang, Xiaoxue Shen, Sujun Hu, Rui Yao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13613320.txt.
Description
Xinyue Zhang and three co-authors single out a gene called MARK4 as a warning sign in mouth cancer. Their 2026 study covers oral squamous cell carcinoma, the most common cancer of the mouth, known for fast spread and poor outlook. The team mined a large public cancer database for gene and outcome data.
Tumors carried far more MARK4 than healthy mouth tissue, and high levels tracked with later stage and shorter survival. Genes active alongside it pointed to cell scaffolding, immune response, and energy pathways. High MARK4 also went with fewer killer immune cells inside the tumor. Silencing the gene in cancer cells slowed their growth and invasion in the lab. The authors name MARK4 a candidate marker and drug target, pending stronger proof.
Catalog record
| CREATOR | Xinyue Zhang, Xiaoxue Shen, Sujun Hu, Rui Yao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |